31 – 40 of 69
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
(
- Contribution to journal › Article
- 2019
-
Mark
Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events
(
- Contribution to journal › Article
-
Mark
Assessing the Nationwide Impact of a Registry-Based Randomized Clinical Trial on Cardiovascular Practice
(
- Contribution to journal › Article
-
Mark
Heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial
(
- Contribution to journal › Article
-
Mark
Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes : A Predefined Subgroup Analysis From the DETO2X-AMI Trial
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden : a report from the Swedish Coronary and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
-
Mark
Quantitative flow ratio for immediate assessment of nonculprit lesions in patients with ST-segment elevation myocardial infarction—An iSTEMI substudy
(
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management : A prespecified subgroup analysis from VALIDATE-SWEDEHEART
(
- Contribution to journal › Article
- 2018
-
Mark
Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction : SWEDEHEART observational study 1998-2013
(
- Contribution to journal › Article